Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis Technologies, Inc. (Nasdaq: ACLS) announced multiple follow-on shipments of its Purion M™ SiC medium current implanter to leading power device manufacturers in Europe. This first-quarter shipment supports the growing demand for silicon carbide (SiC) power devices, particularly in the automotive, mobile, and IoT sectors. Executive Vice President Bill Bintz highlighted the importance of enhancing manufacturing capabilities to meet supply challenges driven by increasing electrification in the automotive industry.
Axcelis Technologies (Nasdaq: ACLS) announced multiple shipments of its Purion VXE™ high energy systems to leading manufacturers of CMOS image sensors. These systems are designed to meet the demands of increased productivity in the semiconductor industry. Axcelis emphasizes its leadership in high-energy implant technology, which is critical for the image sensor market, projected to maintain strong growth driven by the IoT, mobile, and automotive sectors. The Purion product family offers various options for customized energy levels.
On March 8, 2021, Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its first Purion H200 SiC Power Series™ implanter. This advanced equipment, designed for silicon carbide applications, was sent to a key power device manufacturer to support production ramp-up. The Purion H200 is the only single wafer high current implanter tailored for high dose implant applications. CEO Mary Puma highlighted the growing market for power devices, which represented over 17% of 2020 system sales, signaling significant revenue potential for Axcelis.
Axcelis Technologies (Nasdaq: ACLS) has announced its participation in two upcoming virtual investor conferences. The first is the Susquehanna Financial Group Tenth Annual Technology Conference on March 9, 2021, where management will engage in virtual one-on-ones and small group meetings. The second is the B. Riley Inaugural Clean Tech and Sustainability Virtual Investor Conference on March 10, 2021, featuring a fireside chat at 10:30 am EST with subsequent one-on-one meetings. A replay of the latter event will be available afterward.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its second Purion XEmax high energy evaluation system to a leading foundry in the Asia Pacific region, aimed at CMOS image sensor manufacturing. This shipment, part of the first quarter, aligns with Axcelis' goal of reaching a $650M target business model amid increasing demand for high energy implants in the image sensor market. The Purion XEmax features enhanced capabilities, including patented Boost Technology™ for precise control, and builds on the established Purion XE platform for improved photodiode performance.
Axcelis Technologies (ACLS) reported strong financial results for Q4 and full year 2020. Q4 revenue reached $122.2 million, up from $110.4 million in Q3. Net income rose to $14.7 million or $0.43 per diluted share, benefiting from a $0.11 tax benefit. For the year, revenue surged to $474.6 million, a 38% increase from 2019, with net income of $50.0 million and diluted EPS of $1.46. Looking ahead, Q1 2021 revenue is expected between $118 million and $138 million.
Axcelis Technologies (Nasdaq: ACLS) has announced the shipment of its Purion H200™ high current implanter to a second leading power device manufacturer. This shipment aims to support production ramp for silicon power devices and reflects Axcelis's growth strategy in the power device market. The Purion H200 is notable for its versatility, precision, and productivity, catering to a wide energy range from 5keV to 200keV. This system is designed to meet the unique needs of foundry and power device manufacturers, enhancing their ability to develop advanced material modification applications.
Axcelis Technologies (Nasdaq: ACLS), a key player in ion implantation solutions for the semiconductor industry, will participate in B. Riley Securities' Vision Day on January 28, 2021. The event features a fireside chat with Kevin Brewer, executive vice president and CFO, and Doug Lawson, executive vice president of corporate marketing and strategy, scheduled for 3:30 p.m. EST. A webcast replay will be available post-event. Founded over 40 years ago, Axcelis is dedicated to enhancing semiconductor manufacturing processes. For more information, visit www.axcelis.com.
Axcelis Technologies (Nasdaq: ACLS) updated its fourth quarter 2020 financial guidance, expecting revenue of approximately $120 million, exceeding previous guidance of $110 million. Gross margin is projected at 43%, improved from 41%, with earnings per share rising to $0.32 from $0.21. The company also announced a $100 million share repurchase program for 2021, indicating strong confidence in operational prospects. Upcoming financial results will be disclosed on February 10, 2021, with a conference call scheduled for February 11, 2021.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 23rd Annual Needham Virtual Growth Conference from January 11-15, 2021. Key executives including President and CEO Mary Puma, CFO Kevin Brewer, and EVP Doug Lawson will engage in a fireside chat on January 13 at 11:30 a.m. EST. The event will include one-on-one meetings and a live webcast accessible on their website. Axcelis, based in Beverly, Mass., specializes in ion implantation solutions for the semiconductor industry, boasting over 40 years of experience.